Efficacy News and Research

RSS
FDA recognizes safety and efficacy of True Results LAP-BAND device

FDA recognizes safety and efficacy of True Results LAP-BAND device

Fast Company ranks NovaBay 7th in biotech industry in 2011 annual list of world's most innovative companies

Fast Company ranks NovaBay 7th in biotech industry in 2011 annual list of world's most innovative companies

EMA grants Prima BioMed Scientific Advice for CVac ovarian cancer vaccine Phase III trial

EMA grants Prima BioMed Scientific Advice for CVac ovarian cancer vaccine Phase III trial

New tuberculosis vaccine provides better protection

New tuberculosis vaccine provides better protection

EGS publishes three clinical studies on TIF procedure over past four months

EGS publishes three clinical studies on TIF procedure over past four months

Tibotec begins enrollment in TMC435 phase 3 trial for treatment of HCV

Tibotec begins enrollment in TMC435 phase 3 trial for treatment of HCV

TI Pharma launches new research project on stem cell transplant

TI Pharma launches new research project on stem cell transplant

Positive interim data from cabozantinib Phase 2 metastatic castration-resistant prostate cancer trial

Positive interim data from cabozantinib Phase 2 metastatic castration-resistant prostate cancer trial

BDSI announces over 50% enrolled in BEMA Buprenorphine Phase 3 study in chronic pain

BDSI announces over 50% enrolled in BEMA Buprenorphine Phase 3 study in chronic pain

Urocidin Phase III non-muscle-invasive bladder cancer trial interim results to be presented at EAU, AUA conferences

Urocidin Phase III non-muscle-invasive bladder cancer trial interim results to be presented at EAU, AUA conferences

Micell initiates enrollment in DESSOLVE II MiStent Drug-Eluting Coronary Stent System trial

Micell initiates enrollment in DESSOLVE II MiStent Drug-Eluting Coronary Stent System trial

Research: Urban children spend more time playing outdoors

Research: Urban children spend more time playing outdoors

Cytochroma initiates CTAP101 repeat-dose safety, efficacy study in vitamin D insufficiency, SHPT and CKD

Cytochroma initiates CTAP101 repeat-dose safety, efficacy study in vitamin D insufficiency, SHPT and CKD

Iris Pharma announces validation of new EIU model of ocular inflammation

Iris Pharma announces validation of new EIU model of ocular inflammation

Inspire fourth quarter revenues increase 2% to $30.3 million

Inspire fourth quarter revenues increase 2% to $30.3 million

Researchers develop new pneumococcal vaccine through novel discovery approach

Researchers develop new pneumococcal vaccine through novel discovery approach

FDA, Threshold enter agreement on SPA for TH-302 Phase 3 trial in patients with soft tissue sarcoma

FDA, Threshold enter agreement on SPA for TH-302 Phase 3 trial in patients with soft tissue sarcoma

Amicus to present additional positive data from Amigal Phase 2 extension study for Fabry disease

Amicus to present additional positive data from Amigal Phase 2 extension study for Fabry disease

Astellas, AVEO enter development, commercialization agreement for tivozanib

Astellas, AVEO enter development, commercialization agreement for tivozanib

Vical announces issuance of U.S. Patent for cytomegalovirus vaccines

Vical announces issuance of U.S. Patent for cytomegalovirus vaccines

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.